Finley John David
CEO CFO
Finley John David has filed 4 SEC Form 4 filings (9 transaction rows) across 1 company, with disclosures dating back to 2026. 4 of those filings fall inside the rolling window. Most recent filing: Oct 8, 2026.
On the most recent filing, Finley John David is listed as CEO, CFO at PALISADE BIO, INC. Inside the rolling window, Finley John David reported no open-market purchases and 2 open-market sales totaling $310K in PALI. The largest disclosed transaction in the window is a sale of 146,798 PALI shares on Jul 7, 2026, worth $303K.
Companies traded
Other insiders at PALI
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$310K
reported sales (SEC code S)
Companies
1
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has Finley John David made?
Finley John David has filed 4 SEC Form 4 filings (9 transaction rows) across 1 company since 2026.
Which companies does Finley John David trade?
Finley John David has filed SEC Form 4 disclosures for 1 company, including PALI.
When was Finley John David's most recent SEC Form 4 filing?
Finley John David's most recent SEC Form 4 filing on Tracefour is dated Oct 8, 2026.
What is Finley John David's job title?
On the most recent SEC Form 4 filings tracked by Tracefour, Finley John David is listed as CEO CFO.
What is Finley John David's total buy and sell value in the current window?
Inside the rolling retention window, Finley John David bought $0 and sold $310K based on SEC Form 4 filings.
What was Finley John David's largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 146,798 PALI shares on 2026-07-07, worth $303K, per SEC Form 4 filings.